The Best Indian Food in New York City

The Best Indian Food in New York City

You rarely get the best food at the most expensive Indian restaurants, given the amount of labor, fresh ingredients and skill involved in cooking good Indian dishes. Only one of two dishes are good. 

So, instead of paying high prices, you can have good Indian food at cheap and moderately priced restaurants.

The restaurants listed here serve good, cheap to moderately priced Indian food.

The Best Indian Vegetarian Food in New York City:

CHENNAI GARDEN


Image result for chennai garden restaurant new york




Buffet lunch weekdays: $9.95


Address: 127 E 28th St, New York, NY 10016
Hours: 
Open today · 11:30AM–3PM, 5–10PM
Phone: (212) 685-7301
Menu: places.singleplatform.com





The Best Cheap Indian Non Vegetarian Food in New York

MINAR: Cheap with self-service and plastic chairs and formica tables.



Various locations: 5 west 31 street; 
44 street lex and 3rd, near 3rd ave south side; 
46 street 138 west 6th and 7th

DOABA DELI: good North Indian veg and non veg food; taxi driver clientele; tight seating for a total of 8; plastic furniture.
107 st and Columbus

THE BEST MODERATELY PRICED INDIAN NON-VEG FOOD

 PIPPALI: This is run by the same owner of Chennai Garden.
Address: 129 E 27th St, New York, NY 10016
Phone: (212) 689-1999
Menu: places.singleplatform.com

DARBAR  157 E 55th St
Moderate


Comments

Post a Comment

Popular posts from this blog

Satish Mehta CEO of Emcure Pharmaceuticals and a Drug Price-Fixing Scandal

The Billionaire And The Drug Price-Fixing Scandal. Forbes article Satish Mehta founded Emcure Pharmaceuticals in 1981. In 2011 Emcure bought U.S. based Heritage Pharmaceuticals founded by Jeffrey Glazer. In 2016 Heritage had U.S. sales of $265 million, 40% of Emcure's total sales. An article in Forbes , by Nathan Vardi and Nazneen Karmali April 25, 2017, says that, " In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his U.S. crown jewel, Heritage Pharmaceuticals, on a job well done. "In a short span of 4.5 years, you have taken Heritage to another level," Mehta wrote, adding that he considered Glazer to be "an integral part of our family." In January this year, the article continues, "Glazer pleaded guilty to violating U.S. antitrust law by conspiring with manufacturers to fix the prices of generic drugs. Glazer is
Read more

Why Second Generation Indians in U.S. will not be as Successful:

Image
The Bamboo Ceiling for Asians at U.S. Colleges Extract from "Six Degrees of Education: From Teaching in Mumbai to Investment Research in New York" by Ignatius Chithelen  Published by India Today Online August 3, 2016  Why Second Generation Indians in the U.S. will not be as Successful S ince the 1980s, several million Indians have studied at U.S. colleges. Over a million have stayed on in the U.S. through employment visas and many of them have become successful as professionals and some as entrepreneurs. They include chief executives of major U.S. companies such as Sundar Pichai at Google, Satya Nadella at Microsoft, Shantanu Narayen at software vendor Adobe, Indra Nooyi at Pepsico and Rakesh Sachdev of chemicals and bio-chemicals supplier Sigma-Aldrich. Businesses founded or co-founded by Indians in the U.S. include Cascade Communications, Daisy Systems, Epitome, Hotmail, Junglee, Morphotek, Solar Junction and TIBCO Software.  Some Indian en
Read more